Health Education Model Led by Community Health Volunteers.

Status Active, not recruiting

Clinical Trial Summary

The goal of this intervention study is to investigate the level of knowledge, attitudes, and behaviors of students on schistosomiasis in Pemba Island. It aims to test the effectiveness of establishing a widely applicable Community Health Volunteers model in the Zanzibar region and explore the feasibility of promoting this model in other areas of Africa. This study also aims to provide valuable insights and references for global schistosomiasis prevention and control efforts.

Clinical Trial Description

The main questions it aims to answer are: Conducting a survey to understand the current knowledge levels, attitudes, and relevant health behaviors of Pemba Island students towards schistosomiasis. Performing qualitative research to analyze the factors influencing students' knowledge, attitudes, and behaviors related to schistosomiasis, as well as observing the facilitators and barriers to conducting health education among student groups, in order to provide a scientific basis for targeted intervention measures. Testing the effectiveness of establishing a widely applicable community health volunteer model in the Zanzibar region and exploring the feasibility of promoting this model in other regions of Africa, thereby providing insights and references for global schistosomiasis prevention and control efforts. Participants will select fourth and fifth grade students from two schools located in high-risk schistosomiasis prevalence areas on Pemba Island, with Kilindi Primary School as the intervention group and Shumba Viamboni or Chambani primary school as the control group from Feb 2024 to Feb 2025. Apart from the KAP survey, urine samples will be collected from students three times at least and the prevalence confirmed to compare the effectiveness of the two groups. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06312462
Study type	Interventional
Source	Pemba Ministry of Health Zanzibar
Contact
Status	Active, not recruiting
Phase	N/A
Start date	January 1, 2024
Completion date	May 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04115072` - Treatment of Female Genital Schistosomiasis (FGS) With Praziquantel: A Proof-of-Concept Study	Phase 2/Phase 3
Not yet recruiting	`NCT05999825` - Sm-p80 Schistosomiasis Challenge Study	Phase 2
Completed	`NCT00463931` - Using Community-Based Volunteers to Reach Non-Enrolled School Aged Children Through Community-Directed Treatment of Schistosomiasis in School-Aged Children in Rural Northern Ghana	N/A
Completed	`NCT00276224` - Iron Supplementation in Schistosomiasis and Soil Transmitted Helminths Control Programmes in Zambia	N/A
Completed	`NCT00215267` - The Effect of Praziquantel Treatment on Schistosoma Mansoni Morbidity and re-Infection Along Lake Victoria, Uganda	N/A
Completed	`NCT03845140` - L-PZQ ODT in Schistosoma Infected Children	Phase 3
Completed	`NCT01512277` - Clinical Trial of Bilhvax,a Vaccine Candidate Against Schistosomiasis	Phase 1
Active, not recruiting	`NCT03910972` - Sm-TSP-2 Schistosomiasis Vaccine in Healthy Ugandan Adults	Phase 1/Phase 2
Completed	`NCT05085470` - Repeated Controlled Human Schistosoma Mansoni Infection	N/A
Completed	`NCT02755324` - Single-sex Controlled Human Schistosomiasis Infection: Safety and Dose Finding	N/A
Recruiting	`NCT05868005` - Delivering a Multi-disease Screening Tool to Migrant Populations	N/A
Active, not recruiting	`NCT01869465` - Evaluation of Strategies for Improved Uptake of Preventive Treatment for Intestinal Schistosomiasis	N/A
Completed	`NCT01553552` - Schistosomiasis Effect on Response to Vaccines, Anaemia and Nutritional Status of Children of Northern Senegal	N/A
Recruiting	`NCT04589390` - Selexipag for the Treatment of Schistosomiasis-Associated Pulmonary Arterial Hypertension	Phase 2
Completed	`NCT02868385` - Repeated Doses of Praziquantel in Schistosomiasis Treatment (RePST)	Phase 3
Recruiting	`NCT05762393` - A Study to Evaluate the Safety, Tolerability, and Immunogenicity of the Sm-p80 + GLA-SE (SchistoShield®) Candidate Vaccine in Healthy Adults in Burkina Faso and Madagascar	Phase 1
Not yet recruiting	`NCT06182176` - Effectiveness and Cost-effectiveness of Integrated Model for Malaria and Helminth Control	N/A
Completed	`NCT05292391` - Safety, Tolerability, and Immunogenicity Study of Sm-p80 + GLA-SE (SchistoShield(R)) Vaccine in Healthy Adults	Phase 1
Completed	`NCT03110757` - A Phase Ib Study of the Safety, Reactogenicity, and Immunogenicity of Sm-TSP-2/Alhydrogel)(R) With or Without AP 10-701 for Intestinal Schistosomiasis in Healthy Exposed Adults	Phase 1
Completed	`NCT01154049` - Study to Evaluate the Safety of the Vaccine Prepared sm14 Against Schistosomiasis	Phase 1